[Mastoscopic axillary lymph node dissection for the patients with breast cancer].
To analyze the clinical effects of mastoscopic axillary lymph node dissection for the patients with breast cancer. Following the liposuction of the axilla, axillary lymph node dissection was performed in 86 breast cancer patients by mastoscopy. The median duration of operation was 55.3 min. The operation time was obviously shorter for the last 76 patients than for the first 10 patients (P < 0.001). The bleeding amount in operation was little, and no patient was intraoperatively transferred to routine open axillary lymph node dissection due to uncontrolled bleeding. A mean number of 15.3 lymph nodes were harvested. 37 patients showed involved lymph nodes. The mean number of involved lymph nodes in these patients was 3.6. There was no intra- and post-operation morbidity. After a median follow-up time of 10.4 months, no axillary relapse or trocar site implantation had occurred. Mastoscopic axillary lymph node dissection (MALND) based on the liposuction of axilla is a minimally invasive and clinical feasible procedure. It manifests the functional and cosmetic effects and satisfies the breast cancer patients to certain extent.